Braun Stacey Associates Inc Jazz Pharmaceuticals PLC Transaction History

Braun Stacey Associates Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$115.19 - $132.77 $430,119 - $495,763	-3,734 Reduced 3.81%	94,289 $11.4 Million
Q4 2023 Jan 23, 2024	SELL	$114.26 - $136.0 $1.36 Million - $1.62 Million	-11,901 Reduced 10.83%	98,023 $12.1 Million
Q3 2023 Nov 21, 2023	SELL	$122.0 - $145.31 $1.29 Million - $1.53 Million	-10,563 Reduced 8.77%	109,924 $14.2 Million
Q2 2023 Jul 28, 2023	SELL	$122.5 - $147.16 $14.6 Million - $17.5 Million	-118,803 Reduced 49.65%	120,487 $14.9 Million
Q1 2023 May 08, 2023	BUY	$133.98 - $160.47 $16.2 Million - $19.4 Million	120,749 Added 101.86%	239,290 $35 Million
Q4 2022 Feb 07, 2023	BUY	$129.72 - $159.85 $31,392 - $38,683	242 Added 0.2%	118,541 $18.9 Million
Q3 2022 Nov 08, 2022	SELL	$126.59 - $161.18 $507,119 - $645,687	-4,006 Reduced 3.28%	118,299 $15.8 Million
Q2 2022 Jul 27, 2022	BUY	$141.59 - $168.66 $1.27 Million - $1.51 Million	8,942 Added 7.89%	122,305 $19.1 Million
Q1 2022 Apr 28, 2022	BUY	$129.64 - $160.7 $8.62 Million - $10.7 Million	66,503 Added 141.92%	113,363 $17.6 Million
Q4 2021 Jan 25, 2022	BUY	$119.87 - $145.67 $5.62 Million - $6.83 Million	46,860 New	46,860 $5.97 Million

511

57.8M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.63B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Braun Stacey Associates Inc with notifications on news.